HLA-E and neoplasm: For instance, introducing an sgRNA library into various tumor cells and categorizing them into in vitro cultures, immunodeficient NSG mice, wild-type mice, and ICB treatment groups, reveals that IFN-induced non-classical MHC class I molecules, Qa-1b/HLA-E, can impede ICB treatment [122].